Collagen Solutions PLC (LON:COS)‘s stock had its “buy” rating reiterated by analysts at Panmure Gordon in a research note issued on Thursday.

Separately, Beaufort Securities reissued a “buy” rating on shares of Collagen Solutions PLC in a report on Tuesday, July 12th.

Collagen Solutions PLC (LON:COS) opened at 7.84 on Thursday. The firm’s market capitalization is GBX 13.44 million. The firm has a 50 day moving average of GBX 8.27 and a 200 day moving average of GBX 7.27. Collagen Solutions PLC has a one year low of GBX 5.00 and a one year high of GBX 11.12.

Collagen Solutions PLC Company Profile

Collagen Solutions plc is a United Kingdom-based holding company. The Company is engaged in supply, development and manufacture of medical grade collagen components and bio materials for use in regenerative medicine, medical devices and in-vitro diagnostics. The Company’s products include CS001, which is a type I Bovine soluble collagen; CS004, which is a type I Acid swollen gel; CS007, which is a titration buffer; CS010, which is a Bovine Dermal fibrous powder; CS013, which is a type I fibrous powder; CS019, which is a type I Bovine soluble collagen; CS022, which is a pulp, and CS028, which is a type I acid soluble collagen.

Receive News & Stock Ratings for Collagen Solutions PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Collagen Solutions PLC and related stocks with our FREE daily email newsletter.